ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

“The One Thing You Want From AN NCI Director: He Will Be Bound By The Facts”

October 28, 1994

ASCO Releases Guideline On Larynx Preservation

July 28, 2006

Rauscher May Set Up New Office To Monitor, Coordinate RFPs And Grants, Stop Duplication

May 2, 1975

Northwestern’s Lurie Center Wins NCI Support Grants

December 10, 1993

NCAB Delays Decision On Organ Site Program Until May Meeting

February 12, 1982